Renalytix Plc (AIM:RENX)
3.300
-0.050 (-1.49%)
Mar 6, 2026, 12:26 PM GMT
Renalytix Employees
Renalytix had 46 employees as of June 30, 2025. The number of employees decreased by 56 or -54.90% compared to the previous year.
Employees
46
Change
-56
Growth
-54.90%
Revenue / Employee
47.60K GBP
Profits / Employee
-323.69K GBP
Market Cap
14.64M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 46 | -56 | -54.90% |
| Jun 30, 2022 | 102 | 45 | 78.95% |
| Jun 30, 2021 | 57 | 49 | 570.59% |
| Jun 30, 2020 | 9 | -1 | -8.60% |
| Jun 30, 2019 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Sareum Holdings | 5 |
| Inspiration Healthcare Group | 214 |
| Cambridge Cognition Holdings | 84 |
| Fusion Antibodies | 24 |
Renalytix News
- 1 year ago - Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US - GlobeNewsWire
- 1 year ago - Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination - GlobeNewsWire
- 1 year ago - Medicare Issues Final Coverage Determination for kidneyintelX.dkd - GlobeNewsWire
- 1 year ago - Renalytix Plc (RNLX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024 - GlobeNewsWire
- 1 year ago - Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15 - GlobeNewsWire
- 2 years ago - Renalytix Announces Financing with Expected Size of up to $4 Million - GlobeNewsWire
- 2 years ago - KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD) - GlobeNewsWire